Diabetes Tablet Franchise in Ahmedabad

Name: Metfoam L Tablet (Metformin 850 mg + Linagliptin 2.5 mg Tablet)
Brand: Metfoam L Tablet
Rating: 4.8 (150 reviews)

Anti Diabetic Medicine Supplier in Mumbai

Diabetes Medicine Distributor in Delhi

Metformin Linagliptin Tablet Manufacturer in Bangalore

Diabetic Tablet Stockist in Hyderabad

Diabetes Tablet Exporter in Chandigarh

Home/Products /metformin-850mg-linagliptin-2-5mg-tablet

Therapeutic

ENDOCRINOLOGY and Hormonal range

Gastroenterology

General and OTC medicines

Gynecology and Fertility

Hepatology

Hypertension/ Blood Pressure

Nutraceuticals, Multivitamins and Multiminerals

Sedative or Antianxiety

Metformin 850 mg + Linagliptin 2.5 mg Tablet Exporter in Maharashtra

Metformin 850 mg + Linagliptin 2.5 mg Tablet by top PCD Pharma

Metformin 850 mg + Linagliptin 2.5 mg Tablet – PCD Pharma Franchise Marketing Material

Diabetes combination tablet product video

Metformin linagliptin tablet literature PDF

Metfoam L Tablet

Composition : Metformin (850mg) + Linagliptin (2.5mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Contact For Business Query

Metfoam L Tablet containing Metformin and Linagliptin is used for the management of type 2 diabetes mellitus. It helps in controlling blood sugar levels and improving overall glycemic control.

Metformin works by reducing glucose production in the liver and improving insulin sensitivity, while Linagliptin enhances insulin secretion by inhibiting DPP-4 enzyme.

The tablet is widely prescribed in diabetic care for long-term management, often used as combination therapy when single agents are not sufficient, leading to consistent demand and repeat usage.

With increasing prevalence of diabetes and growing need for effective combination therapies, this product offers strong business potential for retailers and distributors. Its chronic therapy requirement, steady prescription demand, and wide clinical acceptance make it a reliable product for consistent sales and growth in the anti-diabetic segment.

About the Product

Metfoam L Tablet containing Metformin and Linagliptin is used for the management of type 2 diabetes mellitus. It helps in controlling blood sugar levels and improving overall glycemic control.

Metformin works by reducing glucose production in the liver and improving insulin sensitivity, while Linagliptin enhances insulin secretion by inhibiting DPP-4 enzyme.

The tablet is widely prescribed in diabetic care for long-term management, often used as combination therapy when single agents are not sufficient, leading to consistent demand and repeat usage.

Some patients may experience nausea, diarrhea, abdominal discomfort, headache, or mild hypoglycemia (when combined with other antidiabetics). Rarely, lactic acidosis (from Metformin) or pancreatitis may occur and require immediate medical attention.

Metfoam L Tablet is indicated for the treatment of type 2 diabetes mellitus, especially in patients who require dual therapy for better glycemic control. It helps reduce fasting and postprandial blood glucose levels, improve insulin response, and lower the risk of diabetes-related complications.

This medicine should be used under medical supervision along with proper diet and exercise. Regular monitoring of blood glucose and kidney function is recommended. Patients should avoid excessive alcohol intake to reduce risk of lactic acidosis.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.